Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- Check3 days agoChange DetectedGemini 1 recruitment status is updated to closed; new help/navigation links are added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting is updated from 'Intervention / Treatment' to 'Intervention/Treatment' with the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check11 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5. This indicates a minor update to the site's underlying code or content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a maintenance/update to the site's backend or UI. This change does not modify study content or data.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site software release without altering the clinical study information.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check76 days agoChange DetectedUpdated the location entry from Padua, Italy 35128 to Padova, Italy 35128 in the trial locations.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.